Rosa David J. - Oct 24, 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
Chief Executive Officer (CEO), Director
Signature
By: Stephanie Lim-Ignacio For: Rosa, David J
Stock symbol
ISRG
Transactions as of
Oct 24, 2025
Transactions value $
-$11,264,759
Form type
4
Date filed
10/27/2025, 03:36 PM
Previous filing
Jul 11, 2025
Next filing
Nov 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rosa David J. Chief Executive Officer (CEO), Director 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: Rosa, David J 2025-10-27 0001519593

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $2.15M +27K +11.65% $79.64 259K Oct 24, 2025 Direct F1
transaction ISRG Common Stock Sale -$13.4M -24.5K -9.47% $547.55 234K Oct 24, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -27K -100% $0.00 0 Oct 24, 2025 Common Stock 27K $79.64 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 11, 2026.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $542.16 to $550.21 as follows: 1,075 shares sold at $542.16 to $543.10; 1,000 shares sold at $543.23 to $544.22; 1,830 shares sold at $544.30 to $545.06; 1,300 shares sold at $545.33 to $546.15; 2,346 shares sold at $546.34 to $547.30; 6,919 shares sold at $547.37 to $548.37; 7,257 shares sold at $548.40 to $549.40; and 2,773 shares sold at $549.42 to $550.21. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.